July 17, 2025: EU Clears Ozempic for Heart Conditions, Even Though Reports of Side Effects Are Rising Drug regulators in the European Union have given doctors the all-clear to prescribe Ozempic to treat peripheral artery disease, a type of heart condition
Outcome: Skin brightness improvement noted at week 3 in standardized photography
Presented for research literature review only Barbagelata L et al
This ensures that each vial meets rigorous specifications for: Purity (99%) Identity verification Sterility and microbial testing Endotoxin levels (where applicable) Our COAs are batch-specific and can be provided upon request
however, it is sold strictly for research use only
The primary endpoint was the incidence of MACEs (cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, hospitalization for heart failure)